Catalyst Wire Dossier Catalyst Wire Dossier

LMIS 50 mg

LMIS 50 mg · Foresee Pharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMIS 50 mg, covering 2018-09-12 to 2018-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg [Phase 3]

See pricing